美国再生医学联盟创始成员

botizhou

Charter Members
+ P& V! ]' j2 f2 m* vCompanies8 B2 r/ Z0 O# L6 |4 q/ R/ Z
Aastrom Biosciences* J9 [. D4 o* m3 l' U" I+ L0 H$ e
Advanced BioHealing
6 _( ~- b: |. G2 ^5 m  gAdvanced Cell Technology 2 j9 g5 D, d  C$ M; o3 E
Aldagen2 p; l! l' [( @. \* v& Q* m
Allosource
: g* s+ y' q7 RATCC® The Global Bioresource Center™
) r8 i" V- E: w5 J! |# s4 |+ v& S: CAthersys
6 _( J8 ^" a; `, E, c3 eBeckman Coulter
9 O+ y+ {9 G) a* O. E! t& q9 E- fCelgene Cellular Therapeutics" i6 y' P( J9 u& `! R( c4 H
Cellerant Therapeutics2 y- E- G3 K* H- @7 ?  r" ~
Corning* {, E4 U; F: g4 P: X( S. h( [
Cytori
; C5 l) ^/ a7 P3 j: y9 K- ZGE Healthcare
- y0 A' w8 o# i& hGeron / F' n  R2 u7 F$ m7 N" }
Fate Therapeutics   G0 Z2 q* n! U, @' K4 G
Fisher BioServices
6 K; c: S9 \0 e# e& i9 u; FInternational Stem Cell Corporation
# Z1 D$ Q3 v' [$ z7 wInvetech% L8 o* m4 `& z
iPierian & o: r5 T+ i3 ?) Q* M! K
ISTO Technologies, Inc.( k! x& C7 Z# R5 q6 E# n- P9 e7 T
Johnson & Johnson 5 d7 J  A2 B9 `2 P
MaxCyte3 ?. ?. M  w8 \- {2 f# M
Millipore
9 s& Y# d4 B( O. D) F! T; @' i' k" [: hOrganovo
; m' J; H0 y# @8 ~5 d& LOrganogenesis2 A( }# B" s! k7 ?
Roji Pharma
+ k, i0 J1 u! O; [Pervasis Therapeutics Inc.
, m! m, h& |' ^& MPfizer Inc
) z! ~5 \+ A! M* JRegenesis Biomedical: z0 z0 M1 o' k
StemCells Inc.- K3 i+ z7 D, r
Theregen! O9 i% w5 ]/ G1 Z1 N
Tengion - L- T3 r% M# D6 V
Tissue Genesis
: Z7 L3 d* E$ j/ k6 D7 W1 [: ^( UViaCyte (formerly Novocell)
8 \7 T- M4 y, l) f& u, DFoundations/Associations/ f( Z5 I! f# S" F: v  i9 K
Alliance for Aging Research
$ ^0 z! t+ c2 H5 ZALS Association
9 _2 n" O2 b' Q5 I/ c, C0 iAssociation of Clinical Research Organizations (ACRO)
( }; r8 L" d  K2 QCalifornians for Cures3 v! Y5 ]- a* k
Foundation for Regenerative Medicine (Founding Member)
/ V( @6 t! v% A! wGenetics Policy Institute
5 |$ |% Y8 m+ J9 xJuvenile Diabetes Research Foundation ! r, {' _- {- u( d: o
New York Stem Cell Foundation " l& `5 y( ]& d9 l0 h: j4 B  ]6 _0 ?
Pittsburgh Tissue Engineering Initiative " O, E0 \; a) y1 K* \0 `) V% i+ a
Research Institutions
: \7 l& a: T/ w0 m4 x6 B# M1 BBurnham Institute for Medical Research
7 c8 d( Z5 R* @: I. @. pThe Cleveland Clinic
3 I6 |1 P8 Q, O2 K- ZUniversity of Louisville & Jewish Hospital Cardiovascular Innovation Institute
" R+ U& C0 E  D0 r1 W; \University College London0 q* U$ G! E& V
Wake Forest Institute for Regenerative Medicine
) X" d7 W% s$ UInvestors7 ~! U4 V- I7 g) ]
Kleiner, Perkins, Caufield, Byers
8 @- D! \& O$ o' h7 gProteus Venture Partners4 m3 L. g2 T( `% u; ]/ G
Safeguard Scientific ! ]; J5 ~" y0 k  n
Toucan Capital